Cargando…
Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure
Heart failure is characterized by the inability of the heart to pump effectively and generate proper blood circulation to meet the body’s needs; it is a devastating condition that affects more than 100 million people globally. In spite of this, little is known about the mechanisms regulating the tra...
Autores principales: | Yan, Youchen, Long, Tianxin, Su, Qiao, Wang, Yi, Chen, Ken, Yang, Tiqun, Zhao, Guangyin, Ma, Qing, Hu, Xiaoyun, Liu, Chen, Liao, Xinxue, Min, Wang, Li, Shujuan, Zhang, Dihua, Yang, Yuedong, Pu, William T., Dong, Yugang, Wang, Da-Zhi, Chen, Yili, Huang, Zhan-Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970336/ https://www.ncbi.nlm.nih.gov/pubmed/35369338 http://dx.doi.org/10.3389/fcvm.2022.857049 |
Ejemplares similares
-
Circle the Cardiac Remodeling With circRNAs
por: Yang, Tiqun, et al.
Publicado: (2021) -
Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression
por: Han, Yanchuang, et al.
Publicado: (2022) -
The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy
por: Yan, Youchen, et al.
Publicado: (2021) -
Maf1 ameliorates cardiac hypertrophy by inhibiting RNA polymerase III through ERK1/2
por: Sun, Yu, et al.
Publicado: (2019) -
Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)